The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Albireo Pharma, Inc(NASDAQ:ALBO) 
Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transpor...
Website: http://www.albireopharma.com
Full Time Employees: 90 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Albireo Pharma Days Payable Outstanding ttm (DPO)
Albireo Pharma Days Receivable Outstanding ttm (DSO)
Albireo Pharma Days Inventory Outstanding ttm (DIO)
Albireo Pharma Op Cashflow Per Share ttm
Albireo Pharma Free Cashflow Per Share ttm
Albireo Pharma Cash Per Share ttm
Albireo Pharma P/S ratio ttm
Albireo Pharma (GAAP) P/E ratio ttm
Albireo Pharma P/B ratio ttm
No extra charts and metrics for this ticker.